NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
NEUROONE MEDICAL TECHNOLOGIES Corp insider trading
NEUROONE MEDICAL TECHNOLOGIES Corp is on this site because an insider bought its stock on the open market in the last 30 days. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
From SEC filings · last 30 days
Recent NMTC insider transactions
The filing store could not be read just now — this page tries again on its next refresh. The filings themselves are on SEC EDGAR.
SEC Form 4 data, Q3 2024 to Q2 2026
NMTC insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded NMTC on the open market: 3 purchases worth $820K and 11 sales worth $64K. In the last four quarters alone: 1 purchase ($670K) and 6 sales ($45.3K), by 2 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | +$670K1 buy | −$23.1K5 sales | |
| Q4 2025 | — | — | |
| Q3 2025 | — | −$22.2K1 sale | |
| Q2 2025 | +$150K2 buys | −$18.7K5 sales | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$670K of NMTC by Wambeke David J. (Chief Business Officer) on Mar 01, 2026.
- Largest sale
- −$22.2K of NMTC by Christianson Mark (Business Development Director) on Sep 05, 2025.
Open-market transactions through Jun 30, 2026most recent first
Christianson Mark
Business Development Director
−$11.4K
Mar 30, 2026
15,364 sh · $0.74
Christianson Mark
Business Development Director
−$80
Mar 13, 2026
100 sh · $0.80
Christianson Mark
Business Development Director
−$654
Mar 12, 2026
818 sh · $0.80
Christianson Mark
Business Development Director
−$1.7K
Mar 11, 2026
2,109 sh · $0.80
Christianson Mark
Business Development Director
−$9.3K
Mar 10, 2026
11,611 sh · $0.80
Wambeke David J.
Chief Business Officer
+$670K
Mar 01, 2026
1,000,000 sh · $0.67
Christianson Mark
Business Development Director
−$22.2K
Sep 05, 2025
30,000 sh · $0.74
Christianson Mark
Business Development Director
−$5.8K
Jun 04, 2025
10,000 sh · $0.58
Christianson Mark
Business Development Director
−$5.6K
May 22, 2025
8,968 sh · $0.62
Christianson Mark
Business Development Director
−$9
May 21, 2025
14 sh · $0.65
Christianson Mark
Business Development Director
−$2K
May 20, 2025
3,014 sh · $0.66
Christianson Mark
Business Development Director
−$5.4K
May 19, 2025
8,006 sh · $0.67
McClurg Ronald W.
Chief Financial Officer
+$100K
Apr 04, 2025
200,000 sh · $0.50
Rosa David A
CEO and President · Director
+$50K
Apr 04, 2025
100,000 sh · $0.50
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 30, 2026 | Christianson MarkBusiness Development Director | 15,364 | $0.74 | −$11.4K |
| Mar 13, 2026 | Christianson MarkBusiness Development Director | 100 | $0.80 | −$80 |
| Mar 12, 2026 | Christianson MarkBusiness Development Director | 818 | $0.80 | −$654 |
| Mar 11, 2026 | Christianson MarkBusiness Development Director | 2,109 | $0.80 | −$1.7K |
| Mar 10, 2026 | Christianson MarkBusiness Development Director | 11,611 | $0.80 | −$9.3K |
| Mar 01, 2026 | Wambeke David J.Chief Business Officer | 1,000,000 | $0.67 | +$670K |
| Sep 05, 2025 | Christianson MarkBusiness Development Director | 30,000 | $0.74 | −$22.2K |
| Jun 04, 2025 | Christianson MarkBusiness Development Director | 10,000 | $0.58 | −$5.8K |
| May 22, 2025 | Christianson MarkBusiness Development Director | 8,968 | $0.62 | −$5.6K |
| May 21, 2025 | Christianson MarkBusiness Development Director | 14 | $0.65 | −$9 |
| May 20, 2025 | Christianson MarkBusiness Development Director | 3,014 | $0.66 | −$2K |
| May 19, 2025 | Christianson MarkBusiness Development Director | 8,006 | $0.67 | −$5.4K |
| Apr 04, 2025 | McClurg Ronald W.Chief Financial Officer | 200,000 | $0.50 | +$100K |
| Apr 04, 2025 | Rosa David ACEO and President · Director | 100,000 | $0.50 | +$50K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check NMTC — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
NEUROONE MEDICAL TECHNOLOGIES Corp is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- How much NMTC stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 4 NEUROONE MEDICAL TECHNOLOGIES Corp insiders made 3 open-market purchases worth $820K and 11 sales worth $64K. In the four quarters to Jun 30, 2026: 1 purchase ($670K) and 6 sales ($45.3K). The largest purchase was Wambeke David J. buying $670K on Mar 01, 2026. The largest sale was Christianson Mark selling $22.2K on Sep 05, 2025.
- Where does NMTC insider trading data come from?
- From the Form 4 filings NEUROONE MEDICAL TECHNOLOGIES Corp's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.